circle-image

Short

Trend Resistance

Uptrend Above: 24560

Bull Signal Above: 24700
circle-image

Term

Trend Point Acts

Trend Point: 24460

My PCR: 1.35
599 Range 1099

Bull Market Signal

circle-image

View

Trend Suport

Down Below: 24350

Bear Signal Below: 24200
Short Term View Historic Data

Nifty View Tomorrow: Friday 13 Nov 2026

Day Close

25299
Day High

25384
Day Low

25142
Day Avg

25275
12 Nov 2026
5 SMA

25123
10 SMA

24441
20 SMA

23634
50 SMA

23328
200 SMA

23989
5 EMA

25208
10 EMA

24868
20 EMA

24457
50 EMA

24304
Tomorrow
Resist 2

25540
Resist 1

25420
Mid Point

25300
Suport 1

25180
Suport 2

25060
52W High

26373
52w Low

22179
52w Down

4.07%
52w Up

14.07%
Panic View
Resist 2

25770
Resist 1

25595
Mid Point

25290
Suport 1

24990
Suport 2

24800
5d High

25424
5d Low

24388
10d High

25424
10d Low

22905
Days High & Low 20d High

25424
20d Low

22372
50d High

25424
50d Low

22179
All Avg

24193
FFTH

25079
FTTL

24239
TTTH

24584
TTTL

23567
High & Low Avg TTFH

24407
TFFL

23325
High Avg

24690
Low Avg

23710
All Avg

24200
Nifty Historic Prediction Data

Nifty Last Five Days Moves

SNo. Date Day Close Day High Day Low 5 DMA 10 DMA 20 DMA 50 DMA 200 DMA
1 12 Nov 2026 25299 25384 25142 25123 24441 23634 23328 23989
2 11 Nov 2026 25255 25424 25095 24970 24205 23500 23304 23988
3 09 Nov 2026 25044 25084 24838 24711 23949 23373 23282 23988
4 08 Nov 2026 24986 25131 24985 24464 23720 23239 23263 23991
5 06 Nov 2026 25030 25030 24388 24155 23497 23116 23248 23994
Nifty Historic Data And Moving Avg

Go Back

STANDARD ENGINEERING TECHNOLOGY LIMITED Company has entered into a Target-Based Conditional Distr...

Posted: 06 Mar 2026

STANDARD ENGINEERING TECHNOLOGY LIMITED Company has entered into a Target-Based Conditional Distribution Agreement with API Pharma Pharmaceutical Trading L.L.C, for the Middle East Region as part of its export expansion strategy. The agreement provides for an initial three (3) year performance period with defined annual and cumulative business targets. Subject to achievement of these milestones, the arrangement shall continue for a total tenure of upto ten (10) years. This arrangement is intended to strengthen the Company’s export presence in the Middle East region across: Pharmaceutical manufacturing facilities, Biopharmaceutical and life sciences, Food & Beverages and other process industries. The Middle East region continues to witness sustained investments in pharmaceutical self-sufficiency, biopharma capacity creation, food security programs and diversified industrial infrastructure under long-term economic transformation initiatives. The agreement enables the Company to participate in such export-driven growth opportunities through a performance-linked and riskcalibrated model. While mindful of evolving geopolitical developments in certain parts of the middle east region, the agreement has been prudently structured with commercial protections and periodic review mechanisms.

Market Bits

"In investing, what is comfortable is rarely profitable." — Robert Arnott

Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.